New psychoactive substances (NPS) are a heterogeneous group of substances. They are
associated with a number of health and social harms on an individual and societal level …

Psychoactive substances with chemical structures or pharmacological profiles that are
similar to traditional drugs of abuse continue to emerge on the recreational drug market …

Background New psychoactive substances constitute a growing and dynamic class of
abused drugs in the United States. On July 12, 2016, a synthetic cannabinoid caused mass …

The word “cannabinoid” refers to every chemical substance, regardless of structure or origin,
that joins the cannabinoid receptors of the body and brain and that have similar effects to …

Indole and indazole synthetic cannabinoids (SCs) featuring l-valinate or l-tert-leucinate
pendant group have recently emerged as prevalent recreational drugs, and their use has …

Synthetic cannabinoid receptor agonists (SCRAs) are an evolving class of new psychoactive
substances (NPS) with structurally diverse compounds emerging each year. Due to the rapid …

Synthetic cannabinoid (SC) designer drugs based on indole and indazole scaffolds and
featuring l-valinamide or l-tert-leucinamide side chains are encountered with increasing …

Novel psychoactive substances (NPS) represent significant analytical and interpretive
challenges to forensic and clinical toxicologists. Timely access to case reports and reports of …

Synthetic cannabinoids (SCs) are the largest group of compounds currently monitored in
Europe by the EU Early Warning System on new psychoactive substances. Emerging …

In the last decades, more and more new psychoactive substances (NPS) were introduced on
the drug market which were sold as “legal” alternatives for classic drugs and misused …